Posted inMedical Technology
Medtronic’s latest ingestible PillCam completes first patient GI procedure
Medtronic reported that a patient has completed the first procedure with the latest version of its ingestible camera, used to…
Posted inMedical Technology
FDA expands use of J&J’s Impella heart pumps to pediatric patients
The FDA has opened up the use of Johnson & Johnson’s miniaturized heart pumps to certain pediatric patients, including those…
Posted inMedical Technology
Multiomics startup Pleno raises $25M for commercial launch, plucks new CEO from Illumina
Pleno has plenty to talk about. The multiomics diagnostic startup has raised $25 million ahead of plans to launch its…
Posted inMedical Technology
USPSTF endorses HPV self-collection tests for cervical cancer screening
The U.S. Preventive Services Task Force (USPSTF) has pitched an update to its national guidelines for cervical cancer screening—including self-collection…
Posted inMedical Technology
Capstan Medical collects $110M for robotic heart valve replacements
Capstan Medical has reeled in $110 million to continue its mission of bringing robotic surgery to a previously untouched sector…
Posted inMedical Technology
Artivion nets FDA humanitarian green light for prosthetic aortic tear implant
Artivion has secured a green light from the FDA for its stentlike implant designed to help remodel the interior of…
Posted inMedical Technology
FDA clears AngioDynamics’ NanoKnife pulsed field ablation system for prostate cancer
AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system, designed to precisely target and destroy…
Posted inResearch
Health tech firm Carta Healthcare buys AI company that matches patients to cancer trials
California health tech company Carta Healthcare is upping its artificial intelligence platform with the acquisition of Realyze Intelligence, an oncology-focused…
Posted inMedical Technology
Cala Health raises $50M to spark growth of its wearable hand tremor therapy
After securing Medicare coverage for its wearable neurostimulator to help people control their hand tremors, Cala Health has raised $50…
Posted inMedical Technology
Profound Medical’s CEO discusses the potential of TULSA-PRO for prostate disease treatment
Heath Clendenning: Welcome everyone. Thanks for joining. I'm Heath Clendenning with Fierce Life Sciences. Today, I'm speaking with Arun Menawat, CEO…